Cancer Blog
- Dr. Robert Nagourney -

I’ve long held that there are no bad cancers, just cancers that we can or cannot treat.

Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.

I received a video from an episode of Americas Got Talent, the popular TV program that features up-and-coming performers.

Cancer patients deserve better. Every patient is unique. Their treatment should be as well.

Daniel Werner, a dedicated nurse and a loving fiancé and father, faced the grim reality of a stage 4 colon cancer diagnosis in December 2021

Screening for Pancreatic cancer, even in the highest-risk individuals found not cost effective.

Blood test results offer a “cancer signature” that distinguishes patients with pancreatic cancer from normal individuals.

One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.

Cancer patients approach their diagnosis with a sense of terror. One day they are fine and feeling well and the next, a terminal diagnosis.

Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.

Cancer therapy can be really expensive. But here's the kicker, Functional Profiling costs way less than receiving the incorrect treatment.

Patients with advanced malignancies often seek the expertise of physicians at major institutions.

Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...

Personalized treatment means more cured patients. More people survive cancer when our Functional Profiling system is used before treatment.

Here in 2023, we suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.

There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.

One noteworthy case was a 78-year-old patient successfully treated without surgery.

Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.

Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.

At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.